International Clinical Trial: Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SCY-247 for Intravenous Administration in Healthy Participants

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ACTRN12626000146392) titled 'Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SCY-247 for Intravenous Administration in Healthy Participants' on Feb. 5.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial

Primary Sponsor: SCYNEXIS, Inc.

Condition: Fungal Infections Fungal Infections Infection - Studies of infection and infectious agents

Intervention:

Part 1 (SAD): 4 dosing cohorts are planned: Cohorts A, B, C, D. The starting dose in Part 1 is based on results from pre-clinical pharmacology and toxicology studies. Subsequent dose levels proposed for ...